Efficacy and Safety of Formoterol Delivered Via a New Multidose Dry Powder Inhaler (Certihaler™) in Adolescents and Adults with Persistent Asthma

By LaForce C.   Prenner B.M.   Andriano K.   Lavecchia C.   Yegen Ümit  

Journal of Asthma, Vol. 42, Iss. 2, 2004-03 ,pp. : 101-106

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Mometasone Furoate Dry Powder Inhaler and Fluticasone Propionate Dry Powder Inhaler in Patients with Moderate to Severe Persistent Asthma Requiring High-Dose Inhaled Corticosteroid Therapy: Findings from a Noninferiority Trial

By Harnest Ulf   Price David   Howes Tim   Sussman Gordon  

Journal of Asthma, Vol. 45, Iss. 3, 2008-04 ,pp. : 215-220

Informa Healthcare

Access to resources Recommend Favorite

Reduction in Oral Corticosteroid Use with Mometasone Furoate Dry Powder Inhaler Improves Health-Related Quality of Life in Patients with Severe Persistent Asthma

By Schmier Jordana   Kline Leidy Nancy   Gower Richard  

Journal of Asthma, Vol. 40, Iss. 4, 2003-07 ,pp. : 383-393

Informa Healthcare

Access to resources Recommend Favorite

Formoterol Delivered via the Dry Powder Aerolizer® Inhaler Versus Albuterol MDI and Placebo in Mild-to-Moderate Asthma: A Randomized, Double-Blind, Double-Dummy Trial

By Pleskow W.   LaForce C. F.   Yegen Ü.   Matos D.   Della Cioppa G.  

Journal of Asthma, Vol. 40, Iss. 5, 2003-09 ,pp. : 505-514

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Safety of Mometasone Furoate/Formoterol Combination for Treatment of Patients with Persistent Asthma

By Maspero Jorge F.   Nolte Hendrik   Chérrez-Ojeda Iván    

Journal of Asthma, Vol. 47, Iss. 10, 2010-12 ,pp. : 1106-1115

Informa Healthcare

Access to resources Recommend Favorite